November 4, 2016November 4, 2016

Preclinical Studies Show Promise for Cystic Fibrosis Therapy in Early Clinical Testing

Cystic Fibrosis, News

SPX-101, an investigational drug for the treatment of cystic fibrosis (CF) being developed by Spyryx Biosciences, has shown to be a safe, stable, and efficient therapy in animal models of the ... Read more

June 29, 2016June 29, 2016

Phase 1 Trial Data on RNA-based Therapy for CF to Be Presented at NACFC 2016

Cystic Fibrosis, News

ProQR Therapeutics recently announced that new data from an ongoing proof-of-concept clinical study, called PQ-010-002, evaluating the effect of an RNA-based therapy (QR-010) on cystic fibrosis patients, will be presented at the North American Cystic Fibrosis Conference ... Read more